Charles Schwab Investment Management Inc Puma Biotechnology, Inc. Transaction History

Charles Schwab Investment Management Inc

$521 Billion
Q1 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 118,254 shares of PBYI stock, worth $370,135. This represents 0.0% of its overall portfolio holdings.

Number of Shares

118,254

Previous 117,666 0.5%

Holding current value

$370,135

Previous $358,000 2.23%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$2.76 - $3.88 $1,622 - $2,281	588 Added 0.5%	118,254 $350,000
Q3 2024 Nov 12, 2024	SELL	$2.25 - $4.03 $19,291 - $34,553	-8,574 Reduced 6.79%	117,666 $300,000
Q2 2024 Aug 12, 2024	BUY	$2.92 - $5.83 $311,818 - $622,568	106,787 Added 548.95%	126,240 $411,000
Q4 2022 Feb 13, 2023	BUY	$2.12 - $5.08 $41,240 - $98,821	19,453 New	19,453 $82,000
Q2 2022 Aug 15, 2022	SELL	$1.64 - $3.3 $75,725 - $152,374	-46,174 Reduced 61.57%	28,820 $83,000
Q1 2022 May 13, 2022	SELL	$2.13 - $3.24 $12,051 - $18,331	-5,658 Reduced 7.02%	74,994 $216,000
Q3 2021 Nov 16, 2021	SELL	$6.63 - $9.39 $1.32 Million - $1.87 Million	-199,023 Reduced 71.16%	80,652 $566,000
Q2 2021 Aug 16, 2021	BUY	$8.98 - $11.6 $105,236 - $135,940	11,719 Added 4.37%	279,675 $2.57 Million
Q1 2021 May 17, 2021	SELL	$9.38 - $13.63 $562,987 - $818,072	-60,020 Reduced 18.3%	267,956 $2.61 Million
Q4 2020 Feb 16, 2021	BUY	$7.78 - $12.13 $44,587 - $69,517	5,731 Added 1.78%	327,976 $3.37 Million
Q3 2020 Nov 13, 2020	SELL	$9.5 - $11.14 $2,394 - $2,807	-252 Reduced 0.08%	322,245 $3.25 Million
Q2 2020 Aug 14, 2020	BUY	$7.01 - $13.24 $89,272 - $168,611	12,735 Added 4.11%	322,497 $3.36 Million
Q1 2020 May 15, 2020	SELL	$6.28 - $14.57 $176,009 - $408,353	-28,027 Reduced 8.3%	309,762 $2.62 Million
Q4 2019 Feb 07, 2020	SELL	$6.5 - $10.73 $71,818 - $118,555	-11,049 Reduced 3.17%	337,789 $2.96 Million
Q3 2019 Nov 08, 2019	BUY	$8.75 - $12.85 $1.46 Million - $2.15 Million	167,331 Added 92.19%	348,838 $3.76 Million
Q2 2019 Aug 09, 2019	BUY	$12.3 - $35.76 $88,756 - $258,044	7,216 Added 4.14%	181,507 $2.31 Million
Q1 2019 May 14, 2019	BUY	$20.77 - $42.37 $261,286 - $533,014	12,580 Added 7.78%	174,291 $6.76 Million
Q4 2018 Feb 14, 2019	SELL	$20.07 - $46.7 $36,788 - $85,601	-1,833 Reduced 1.12%	161,711 $3.29 Million
Q3 2018 Nov 13, 2018	BUY	$41.2 - $59.85 $129,780 - $188,527	3,150 Added 1.96%	163,544 $7.5 Million
Q2 2018 Aug 08, 2018	BUY	$48.3 - $68.25 $473,967 - $669,737	9,813 Added 6.52%	160,394 $9.49 Million
Q1 2018 May 07, 2018	BUY	$59.7 - $99.25 $619,865 - $1.03 Million	10,383 Added 7.41%	150,581 $10.2 Million
Q4 2017 Jan 17, 2018	BUY	$93.85 - $132.45 $472,159 - $666,355	5,031 Added 3.72%	140,198 $13.9 Million
Q3 2017 Nov 13, 2017	BUY	$72.0 - $119.75 $9.73 Million - $16.2 Million	135,167	135,167 $16.2 Million

Others Institutions Holding PBYI

# of Institutions

118

Shares Held

31.1M

Call Options Held

32.7K

Put Options Held

200

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $143M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Puma Biotechnology, Inc. Transaction History